Arrayit Corporation (ARYC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2014 | 1.07 Million USD | 40.39% |
| 2013 | 768 Thousand USD | -27.46% |
| 2012 | 1.05 Million USD | -19.74% |
| 2011 | 1.31 Million USD | 7.59% |
| 2010 | 1.22 Million USD | 15.16% |
| 2009 | 1.06 Million USD | -71.34% |
| 2008 | 3.71 Million USD | 72.55% |
| 2007 | 2.15 Million USD | -26.33% |
| 2006 | 2.92 Million USD | 181.23% |
| 2005 | 1.03 Million USD | -3.62% |
| 2004 | 1.07 Million USD | 15.48% |
| 2003 | 933.51 Thousand USD | 34372.49% |
| 2002 | 2708.00 USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2015 Q1 | 1.23 Million USD | 14.59% |
| 2015 Q3 | 924.49 Thousand USD | -9.75% |
| 2015 Q2 | 1.02 Million USD | -17.09% |
| 2014 Q3 | 855.77 Thousand USD | 10.63% |
| 2014 Q4 | 1.07 Million USD | 25.99% |
| 2014 FY | 1.07 Million USD | 40.39% |
| 2014 Q1 | 772.25 Thousand USD | 0.55% |
| 2014 Q2 | 773.5 Thousand USD | 0.16% |
| 2013 Q4 | 768 Thousand USD | -14.65% |
| 2013 Q3 | 899.84 Thousand USD | 0.13% |
| 2013 Q2 | 898.69 Thousand USD | -4.87% |
| 2013 Q1 | 944.72 Thousand USD | -10.77% |
| 2013 FY | 768 Thousand USD | -27.46% |
| 2012 FY | 1.05 Million USD | -19.74% |
| 2012 Q1 | 1.34 Million USD | 2.32% |
| 2012 Q3 | 1.34 Million USD | 0.0% |
| 2012 Q4 | 1.05 Million USD | -21.53% |
| 2011 Q2 | 1.19 Million USD | -1.76% |
| 2011 Q4 | 1.31 Million USD | 7.73% |
| 2011 Q3 | 1.22 Million USD | 2.66% |
| 2011 Q1 | 1.21 Million USD | -0.97% |
| 2011 FY | 1.31 Million USD | 7.59% |
| 2010 Q1 | 1.01 Million USD | -4.28% |
| 2010 FY | 1.22 Million USD | 15.16% |
| 2010 Q4 | 1.22 Million USD | 2.22% |
| 2010 Q3 | 1.19 Million USD | 2.89% |
| 2010 Q2 | 1.16 Million USD | 14.38% |
| 2009 Q1 | 1.75 Million USD | -52.65% |
| 2009 FY | 1.06 Million USD | -71.34% |
| 2009 Q2 | 1.74 Million USD | -0.93% |
| 2009 Q4 | 1.06 Million USD | 0.0% |
| 2008 Q2 | 3.45 Million USD | -5.84% |
| 2008 Q1 | 3.67 Million USD | 70.49% |
| 2008 Q3 | 3.45 Million USD | 0.05% |
| 2008 Q4 | 3.71 Million USD | 7.43% |
| 2008 FY | 3.71 Million USD | 72.55% |
| 2007 Q4 | 2.15 Million USD | 142.15% |
| 2007 FY | 2.15 Million USD | -26.33% |
| 2007 Q1 | 2.98 Million USD | 2.06% |
| 2007 Q2 | 757.72 Thousand USD | -74.59% |
| 2007 Q3 | 888.99 Thousand USD | 17.32% |
| 2006 Q3 | 2.51 Million USD | 170.52% |
| 2006 FY | 2.92 Million USD | 181.23% |
| 2006 Q1 | 930.97 Thousand USD | -10.4% |
| 2006 Q4 | 2.92 Million USD | 16.02% |
| 2006 Q2 | 930.97 Thousand USD | 0.0% |
| 2005 Q1 | 1.14 Million USD | 6.35% |
| 2005 FY | 1.03 Million USD | -3.62% |
| 2005 Q3 | 1.54 Million USD | 14.44% |
| 2005 Q4 | 1.03 Million USD | -32.84% |
| 2005 Q2 | 1.35 Million USD | 17.91% |
| 2004 Q3 | 1.69 Million USD | -20.35% |
| 2004 FY | 1.07 Million USD | 15.48% |
| 2004 Q2 | 2.13 Million USD | 41.59% |
| 2004 Q1 | 1.5 Million USD | 61.37% |
| 2004 Q4 | 1.07 Million USD | -36.54% |
| 2003 Q2 | 103 Thousand USD | 1187.5% |
| 2003 Q4 | 933.51 Thousand USD | 18.09% |
| 2003 Q1 | 8000.00 USD | 195.42% |
| 2003 Q3 | 790.49 Thousand USD | 667.47% |
| 2003 FY | 933.51 Thousand USD | 34372.49% |
| 2002 Q3 | 704.42 Thousand USD | 0.0% |
| 2002 FY | 2708.00 USD | 0.0% |
| 2002 Q4 | 2708.00 USD | -99.62% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | 51.868% |
| Atlantic International Corp. | 2.93 Million USD | 63.209% |
| Biocept, Inc. | 12.1 Million USD | 91.096% |
| Bioqual, Inc. | 3.58 Million USD | 69.942% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -1384.792% |
| DermTech, Inc. | 54.39 Million USD | 98.018% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.772% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 77.696% |
| iMD Companies, Inc. | 1.12 Million USD | 3.748% |
| IDenta Corp. | 789.14 Thousand USD | -36.625% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 90.367% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -2359.042% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 86.598% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | 71.819% |
| NovelStem International Corp. | 3.57 Million USD | 69.838% |
| Optigenex Inc. | 8.94 Million USD | 87.941% |
| PharmChem, Inc. | 77.35 Thousand USD | -1293.827% |
| Proteome Sciences plc | 17.15 Million USD | 93.715% |
| Response Genetics, Inc | 6.37 Million USD | 83.082% |
| Rennova Health, Inc. | 15.32 Million USD | 92.967% |
| RushNet, Inc. | 4.82 Million USD | 77.646% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -420.768% |
| Stella Diagnostics Inc. | 6.2 Million USD | 82.612% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | 40.105% |
| Todos Medical Ltd. | 38.34 Million USD | 97.188% |